Navigation Links
U.S. Women's Health Care Still Falls Short: Report
Date:10/17/2007

11 states as well as District of Columbia receive failing grades

WEDNESDAY, Oct. 17 (HealthDay News) -- The United States isn't making the grade when it comes to women's health, a new report contends.

The report gives the country an overall grade of "unsatisfactory" because it meets only three of 27 benchmarks for women's health. Those benchmarks are the percentage of women aged 40 and over who get regular mammograms; the percentage of women who visit their dentist annually; and the percentage of women aged 50 and over who are screened for colorectal cancer.

Not one state received an overall "satisfactory" grade in the area of women's health. Three states -- Massachusetts, Minnesota and Vermont -- received "satisfactory minus" grades, down from eight states in 2004.

Eleven states, as well as the District of Columbia, received failing grades -- Alabama, Arkansas, Indiana, Kentucky, Louisiana, Mississippi, Oklahoma, South Carolina, Tennessee, Texas, West Virginia -- double the number that failed in 2004.

All other states received a rating of "unsatisfactory," according to the report, released Wednesday by the National Women's Law Center and Oregon Health and Science University.

"As the years pass, states are further behind in the quest to meet national goals for women's health," Judy Waxman, vice president for health and reproductive rights at the National Women's Law Center (NWLC), said during a teleconference. "States have made some progress in adopting policies that could advance women's health as opposed to past report cards, but we still have a long way to go because once policies are in place, it takes a while to make an impact on health status."

Dr. Suzanne Steinbaum, director of Women and Heart Disease at Lenox Hill Hospital in New York City, said she was "absolutely appalled by this study. We're running around the U.S. talking about women and heart disease, and here we have
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Young womens woes
2. Cosmetic Genital Surgery may Be Fuelling Womens Insecurity About Their Bodies
3. Diabetic Womens Death Rate Shows No Decline
4. Rare Womens Lung Disease May Yield Insights Into Common Diseases
5. Womens Mood Plays a Key Role in Infertility Treatment
6. Poor health care in Russia maybe causing Decline in its Population
7. Startling Expose – Physicians Often Have No Regular Source Of Health Car
8. Debate Rages over firing of HIV infected health care workers
9. Want a Healthy brew? Have some Tea!
10. Patient’s perception of health status helps in better recover
11. Antioxidants protect health tissue in people undergoing radiation therapy.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...s Group on Health Recognize the Nation,s Best Heal... WASHINGTON, Dec. 2 As...and human tolls across the country, leaders at the...morial Hermann Healthcare System (Houston, TX) hav...xecutive-suite and extend throughout their organiz...
(Date:12/2/2008)...ire-FirstCall/ -- Cantel Medical Corp. (NYSE: CM...pany,s results for its first quarter ended October...ticipating in the call will be Charles M. Diker, C...heldon, Senior Vice President and CFO; and Roy K. ...h is a Cantel subsidiary. The first quarter result...
(Date:12/2/2008)...people, family gatherings, parties, and other soci...eason. Not so for those with social anxiety disord...eports the December 2008 issue of Harvard Women,s...(Vocus) December 2, 2008 -- For most people, famil... are part of the fun of the holiday season. Not so...
(Date:12/2/2008)...kinnyAndTheCity.com launches as the definitive on...and feel their best. Renowned nutritionist Tan...credited team of experts in the fields of nutritio...all together on one website to offer the most on-t...e market today - all at no cost and no calories to...
Breaking Medicine News(10 mins):Health News:Leaders at Henry Ford Health System and Memorial Hermann Healthcare System Awarded for Commitment to Creating Safer, More Transparent Environments for Patients 2Health News:Leaders at Henry Ford Health System and Memorial Hermann Healthcare System Awarded for Commitment to Creating Safer, More Transparent Environments for Patients 3Health News:Leaders at Henry Ford Health System and Memorial Hermann Healthcare System Awarded for Commitment to Creating Safer, More Transparent Environments for Patients 4Health News:Leaders at Henry Ford Health System and Memorial Hermann Healthcare System Awarded for Commitment to Creating Safer, More Transparent Environments for Patients 5Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008 2Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:SkinnyAndTheCity.com Top Experts Create the Ultimate Lifestyle Guide 2
... HIV have approximately a hundred times greater ri...he general population,// researchers at the US Nat...s were published in the March 1st online edition o...Infectious Diseases. Osteonecrosis or ‘bone d...
...entists have developed a house to help people with...ctivity and sounds a warning when it thinks there ... the Bath Institute of Medical Engineering could m...can now stay in their own homes for longer, rather...
...of new cases diagnosed with cancer among the aging...// and 2006, according to report published. It is... cases of cancer (up from 2.9 million in 2004) and...n the whole of Europe. Professor Peter Boyle, Dir...
...ducted by the scientists at Western Infirmary Epil...racetam is effective as a single therapy. This stu...as a double-blind study which had around six hundr...st two attacks of convulsions in the last year to ...
Other Medicine News:Health News:HIV-positive Individuals Have a Massively Increased Risk of Osteonecrosis 2Health News:HIV-positive Individuals Have a Massively Increased Risk of Osteonecrosis 3Health News:‘Smart House’ Developed to Monitor People With Dement 2Health News:Marked Increase of Cancer Cases Among Aging Population 2Health News:Marked Increase of Cancer Cases Among Aging Population 3Health News:Marked Increase of Cancer Cases Among Aging Population 4
(Date:12/2/2008)..., Calif., Dec. 2 TorreyPines Thera...sitive results from a 26 patient Phase II trial ev...xerostomia, or dry mouth, in patients with Sjogren... statistically significant increase in salivary fl...es: 10 mg, 15 mg, and 20 mg. These doses were safe...
(Date:12/2/2008)...Ill., Dec. 2 Horizon Therapeutics,..., today announced that two pivotal,Phase 3 trials...date, HZT-501,met all primary endpoints. HZT-501...duct containing ibuprofen and famotidine, demonstr... incidence of non-steroidal,anti-inflammatory dru...
(Date:12/2/2008)..., Md., Dec. 2 Micromet, ...y developing novel, proprietary antibodies for the...diseases, today announced that it has entered into...cing Facility (CEFF) with Kingsbridge Capital Limi...of the agreement, Kingsbridge has committed to pro...
(Date:12/1/2008)... Dec. 2 New research ha...slice computed tomography (CT) scanner in an emerg... stroke victims who receive a potentially life-sav...North Shore Medical Center (NSMC)-Salem Hospital i...ual meeting of the Radiological Society of North A...
Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3A tiny pinch from a z ring helps bacteria cells divide 760 1A tiny pinch from a z ring helps bacteria cells divide 760 2A tiny pinch from a z ring helps bacteria cells divide 760 3Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee 1212 1Drug Makers Withdraw Cough Cold Meds for Infants 3468 1Drug Makers Withdraw Cough Cold Meds for Infants 3468 2Drug Makers Withdraw Cough Cold Meds for Infants 3468 3European lead in reading past climates from ice cores 759 1European lead in reading past climates from ice cores 759 2European lead in reading past climates from ice cores 759 3
..., 2007 /PRNewswire-FirstCall/ -- Shire plc,announc...system),the first and only non-oral medication ap...ivity Disorder (ADHD) in children aged 6,to 12 yea...ntrol,and tolerability, according to results of a ...n Psychiatric Association (APA),annual meeting in ...
...(BUSINESS WIRE)--May 23, 2007 - Synta,Pharmaceutic...any,focused on discovering, developing, and commer...ical conditions, today announced,that survival and...ial in metastatic melanoma of the Company,s lead o...d at the annual meeting of the,American Society of...
Other Medicine Technology:12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 212-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 312-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 412-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 512-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 612-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 712-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 812-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA,(methylphenidate transdermal system) 9Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 2Synta Oncology Candidate STA-4783 Clinical Trial Results to Be,Presented at the ASCO Annual Meeting 3
...tal Camera Systems provide the advanced functional...r advanced training. Programmable, easy to activat...ed to accommodate the imaging demands of all endos...le and non-autoclavable camera heads, the new IM32...
...amera System provides easy-to-use features, auto i...e camera head construction is based on Solos durab...ystem for Microscopic Application, Domestic (MS 10...CCU) with power cord and video cables , (MS 1050-0...
...amera System provides easy-to-use features, auto i...e camera head construction is based on Solos durab...Camera System, International (GS9900-PAL) includes... cord and video cables , (GS 9905) Camera head wit...
...ers 800+ lines of resolution along with color bar ...white balance features in a user-friendly design. ...GS 9920-PAL) includes: , (GS 9923) Camera Control ...ead with 3 meter cable (10 ft.)(1/2" format CCD) ...
Medicine Products: